ANSTO is the new production partner of OncoBeta® GmbH in Australia
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
Showing 601 - 620 of 2126 results
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
ANSTO provides eduroam services for partnering institutions in Australia and around the world.
Guidance for obtaining and maintaining human or animal ethics approval at the Australian Synchrotron.
ANSTO provides a summary of water usage and discharge for FY2022 - FY2023
The OPAL research reactor's design and integrated safety features mean it is extremely safe; a fact confirmed by independent analysis.
The sap extracted from Sugar Maple trees, is used to produce maple syrup. There are many conflicting theories and an absence of experimental evidence, regarding the mechanisms involved in maple sap exudation.
Researchers from UNSW have found an extraordinary material that does expand or contract over an extremely wide temperature range and may be one of the most stable materials known.
ANSTO can analyse minute amounts of organic or inorganic matter embedded in a complex material
nandin is ANSTO’s Innovation Centre where science and technology entrepreneurs, startups and graduates meet industry expertise to experiment, co-create, innovate, and commercialise, creating new jobs in the high-growth industries of tomorrow.
ANSTO physicist will gain further experience in particle therapy technologies.
All safety requirements must be met while working at the Australian Centre for Neutron Scattering. Failure to do so may result in the suspension of experiments.
ANSTO has released the Independent Safety Review of Building 23 - Nuclear medicine production facility.